INS and type 2 diabetes mellitus: A similar study of the PaQ (a wearable device) was carried out to determine basal rates and bolus insulin on demand; adults with type 2 diabetes showed improved glycemic control using a PaQ device and were satisfied with the change from daily injections (NCT02419859) [159].